MA-PRECISELY
3.11.2022 14:01:44 CET | Business Wire | Press release
Precisely, the global leader in data integrity, today announced that Devon and Cornwall Police leveraged its GIS software to enhance safety measures during the 2021 G7 Summit – the annual gathering of policy leaders from seven of the world’s major democracies. The local police force combined MapInfo Pro with third-party 3D visualizations to create a digital twin that enabled precise contingency planning – based on a model that had an accuracy of up to five millimeters.
The innovative use of geospatial solutions, alongside cutting-edge 3D technology, has huge implications for security and event planning. Mounting geopolitical tension is increasing the likelihood of security threats, meaning that high profile events, such as Queen Elizabeth II’s recent funeral procession, are requiring unprecedented levels of complex security protocol. The pandemic has also made contingency planning more challenging by limiting the ability to bring together large groups of people to do in-person planning.
“We had two major hurdles we had to cross during the planning phase for the G7 Summit,” said Robert Goldsmith, GIS and Mapping Manager, Devon and Cornwall Police. “The first challenge was managing the sheer volume of security protocols needed for such a high-profile event, particularly given that the Summit was hosted in two locations. This meant that safety measures were required for different venues, as well as for each of the world leaders, as they travelled back and forth. The second was giving visibility to our security partners around the world, especially as the pandemic limited the ability for teams to travel to the site in the run up to the event.”
The force’s GIS team quickly recognized that mapping software could play an important role to easily bring together data from a variety of sources and data formats, providing critical context in the assessment of all safety protocols leading up to and throughout the Summit. As an existing Precisely customer, Devon and Cornwall Police leveraged MapInfo Pro, a powerful desktop mapping solution that unlocks location-based context from data, empowering confident decisions grounded in visualizations of data patterns that would otherwise be hidden.
Goldsmith and his team used MapInfo Pro to generate 2D gridded map books of the venues and enriched it with points of interest (POI) data, such as foot bridges, cell masts, bus stops, and officer and partner locations. External datasets from other GIS units were also fed into the solution to seamlessly connect different formats for maximum context.
The 2D mapping created in MapInfo Pro proved to be the ideal foundation for the team to create cutting edge 3D visualizations. Leveraging capabilities provided by third-party providers, the team used aerial drone footage to build out an initial model. This was further augmented with 360-degree visualizations, using video footage that was meticulously captured by scanning over 140,000 square meters of the Summit venues.
The result was a hyper-accurate virtual representation, or digital twin, of the entire area. This enabled Devon and Cornwall Police and their partners, to anticipate security issues and create contingency plans using virtual reality headsets to remotely access locations during the planning phase. This removed the need to have more individuals on the ground than necessary in the run up to the event, while still enabling highly accurate contingency planning to take place.
“The data was accessible by our partners who could view our venues from any phone, tablet, or laptop, anywhere in the country,” said Goldsmith. “These insights benefitted a wide range of stakeholders such as our firearms, ops planning, and counter drone teams, and even external partners including the U.S. Secret Service, because they were able to understand the risks and opportunities different locations and routes presented.”
The G7 Summit went off without security hitch, with the GIS technology widely credited as being central to its success.
“Location intelligence is a crucial element of data integrity, allowing customers to unlock essential context from their data,” said Clarence Hempfield, Senior Vice President – Product Management at Precisely. “Working with Devon and Cornwall police allowed us to see our solutions in action, alongside third-party technology, to help enhance security at an internationally renowned event involving some of the world’s top leaders. We are incredibly proud to fuel organizations across the globe with the trusted data they need to confidently make critical decisions that better serve and protect their citizens.”
Learn more about how Devon and Cornwall Police used location intelligence for the G7 Summit planning here.
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221020006182/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom